Inventor · disambiguated record
Roberto A. Maldonado
Also filed as: MALDONADO ROBERTO · MALDONADO ROBERTO A
28 granted patents·31 pending applications·513 citations·filing 2011–2025
97Inventor score
Files withSELECTA BIOSCIENCES INC24NOKIA TECHNOLOGIES OY9MALDONADO ROBERTO A8KISHIMOTO TAKASHI KEI6FRASER CHRISTOPHER4
Top patents by PatentIndex Score
59 records- 0197US11298342B2Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivitySELECTA BIOSCIENCES INC·Filed 2019·Granted Apr 12, 2022·7 cites·20 claims
- 0297US10668053B2Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigenSELECTA BIOSCIENCES INC·Filed 2014·Granted Jun 2, 2020·13 cites·16 claims
- 0397US9993548B2Tolerogenic synthetic nanocarriers for inducing regulatory B cellsSELECTA BIOSCIENCES INC·Filed 2014·Granted Jun 12, 2018·30 cites·17 claims
- 0497US8652487B2Tolerogenic synthetic nanocarriers for inducing regulatory B cellsMALDONADO ROBERTO A·Filed 2012·Granted Feb 18, 2014·139 cites·13 claims
- 0596US10441651B2Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cellsSELECTA BIOSCIENCES INC·Filed 2015·Granted Oct 15, 2019·16 cites·15 claims
- 0696US10420835B2Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cellsSELECTA BIOSCIENCES INC·Filed 2015·Granted Sep 24, 2019·17 cites·19 claims
- 0796US10039822B2Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responsesSELECTA BIOSCIENCES INC·Filed 2015·Granted Aug 7, 2018·31 cites·24 claims
- 0896US9987354B2Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cellsFRASER CHRISTOPHER·Filed 2012·Granted Jun 5, 2018·29 cites·16 claims
- 0996US9295718B2Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteinsFRASER CHRISTOPHER·Filed 2012·Granted Mar 29, 2016·33 cites·14 claims
- 1096US9289476B2Tolerogenic synthetic nanocarriers for allergy therapyKISHIMOTO TAKASHI KEI·Filed 2012·Granted Mar 22, 2016·30 cites·8 claims
- 1196US9289477B2Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responsesFRASER CHRISTOPHER·Filed 2012·Granted Mar 22, 2016·30 cites·12 claims
- 1295US11235057B2Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responsesSELECTA BIOSCIENCES INC·Filed 2018·Granted Feb 1, 2022·8 cites·17 claims
- 1395US10434088B2Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective doseSELECTA BIOSCIENCES INC·Filed 2014·Granted Oct 8, 2019·15 cites·22 claims
- 1495US10357483B2Methods comprising dosing combinations for reducing undesired humoral immune responsesSELECTA BIOSCIENCES INC·Filed 2014·Granted Jul 23, 2019·14 cites·20 claims
- 1595US10357482B2Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivitySELECTA BIOSCIENCES INC·Filed 2014·Granted Jul 23, 2019·16 cites·20 claims
- 1694US10004802B2Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cellsKISHIMOTO TAKASHI KEI·Filed 2012·Granted Jun 26, 2018·20 cites·18 claims
- 1794US9265815B2Tolerogenic synthetic nanocarriersFRASER CHRISTOPHER·Filed 2012·Granted Feb 23, 2016·50 cites·10 claims
- 1893US11779641B2Tolerogenic synthetic nanocarriers for allergy therapySELECTA BIOSCIENCES INC·Filed 2016·Granted Oct 10, 2023·3 cites·18 claims
- 1992US11717569B2Tolerogenic synthetic nanocarriersSELECTA BIOSCIENCES INC·Filed 2016·Granted Aug 8, 2023·5 cites·19 claims
- 2091US2025177360A1Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective doseCARTESIAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2190US2024261396A1Tolerogenic synthetic nanocarriers for allergy therapySELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2288US11860995B2Method to implement traceability and provability in software developmentUS NAVY·Filed 2021·Granted Jan 2, 2024·3 cites·1 claims
- 2388US2023321225A1Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteinsSELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2487US2023321224A1Tolerogenic synthetic nanocarriers to reduce antibody responsesSELECTA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2587US2023310593A1Tolerogenic synthetic nanocarriers for allergy therapySELECTA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2686US2024156955A1Tolerogenic synthetic nanocarriersSELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2783US12472167B2Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both Type 1 and Type IV hypersensitivityCARTESIAN THERAPEUTICS INC·Filed 2022·Granted Nov 18, 2025·0 cites·20 claims
- 2881US11997644B2Handling of paging messages in communication endpoint to network relaying scenariosNOKIA TECHNOLOGIES OY·Filed 2019·Granted May 28, 2024·4 cites·19 claims
- 2981US2020101155A1Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cellsSELECTA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3081US2020101154A1Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cellsSELECTA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3179US2020113874A1Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective doseSELECTA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3279US2022354947A1Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responsesSELECTA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3376US12508249B2Methods related to administering immunosuppressants and non-allergenic antigens to reduce or prevent anaphylaxisCARTESIAN THERAPEUTICS INC·Filed 2020·Granted Dec 30, 2025·0 cites·23 claims
- 3473US2020069660A1Methods comprising dosing combinations for reducing undesired humoral immune responsesSELECTA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 3562US2013059009A1Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriersKISHIMOTO TAKASHI KEI·Filed 2012·Application pending·0 cites
- 3662US2013058976A1Allergen-specific induced tolerogenic dendritic cells for allergy therapyKISHIMOTO TAKASHI KEI·Filed 2012·Application pending·0 cites
- 3762US2013058902A1Dendritic cell subsets for generating induced tolerogenic dendritic cells and related compositions and methodsKISHIMOTO TAKASHI KEI·Filed 2012·Application pending·0 cites
- 3862US2013058970A1Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokinesKISHIMOTO TAKASHI KEI·Filed 2012·Application pending·0 cites
- 3961US2013058974A1Antigen-specific induced tolerogenic dendritic cells to reduce cytotoxic t lymphocyte responsesMALDONADO ROBERTO A·Filed 2012·Application pending·0 cites
- 4061US2013058978A1Induced tolerogenic dendritic cells for inducing regulatory b cellsMALDONADO ROBERTO A·Filed 2012·Application pending·0 cites
- 4161US2013058975A1Antigen-specific induced tolerogenic dendritic cells to reduce antibody responsesMALDONADO ROBERTO A·Filed 2012·Application pending·0 cites
- 4261US2013058894A1Therapeutic protein-specific induced tolerogenic dendritic cells and methods of useMALDONADO ROBERTO A·Filed 2012·Application pending·0 cites
- 4361US2013058977A1Compositions and methods related to induced tolerogenic dendritic cells externally loaded with mhc class i-restricted epitopesMALDONADO ROBERTO A·Filed 2012·Application pending·0 cites
- 4461US2013058963A1Induced tolerogenic dendritic cells for generating cd8+ regulatory t cellsMALDONADO ROBERTO A·Filed 2012·Application pending·0 cites
- 4561US2013058901A1Transplantable graft-specific induced tolerogenic dendritic cells and methods of useMALDONADO ROBERTO A·Filed 2012·Application pending·0 cites
- 4660US12088433B2Methods and apparatus for performing channel estimation on flexible duplexing slots based on additional assistance information signals from at least one neighbor base stationNOKIA TECHNOLOGIES OY·Filed 2023·Granted Sep 10, 2024·0 cites·33 claims
- 4758US12407440B2Method, apparatus and computer programNOKIA SOLUTIONS & NETWORKS OY·Filed 2024·Granted Sep 2, 2025·0 cites·14 claims
- 4858US2025287430A1Methods for beam specific power controlNOKIA TECHNOLOGIES OY·Filed 2023·Application pending·0 cites
- 4957US12144026B2Channel access procedureNOKIA TECHNOLOGIES OY·Filed 2021·Granted Nov 12, 2024·0 cites·13 claims
- 5056US11849509B2Apparatus, method, and computer programNOKIA TECHNOLOGIES OY·Filed 2021·Granted Dec 19, 2023·0 cites·20 claims
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Roberto A. Maldonado files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →